Article Text

Download PDFPDF

Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis
Free
  1. C G Elliott1,
  2. H I Palevsky2
  1. 1Departments of Medicine, Pulmonary and Critical Care Divisions, LDS Hospital and the University of Utah School of Medicine, Salt Lake City, USA
  2. 2Department of Medicine, Pulmonary and Critical Care Division, Presbyterian Medical Center, University of Pennsylvania Health System, USA
  1. Correspondence to:
    Professor C G Elliott
    Pulmonary Division, LDS Hospital, Salt Lake City, UT 84143; ldgellioihc.com

Abstract

Pulmonary hypertension frequently complicates mitral stenosis. Increased pulmonary artery pressure results from raised left atrial pressure, pulmonary arteriolar constriction, and obliterative changes in the pulmonary vascular bed, and usually responds to surgical relief of mitral stenosis. However, severe pulmonary hypertension may persist after surgical treatment of mitral stenosis. We describe a patient whose severe pulmonary hypertension following mitral valve replacement was treated successfully with continuous intravenous epoprostenol.

  • pulmonary hypertension
  • mitral stenosis
  • epoprostenol

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes